Here is Claude 3's system prompt!
Let me break it down 🧵

Students said they were given little information about when and if the devices would be returned, and many wondered if they’d lose access to the work they saved.

The lack of a cooling fan on the M3 MacBook Air has severe consequences, as it throttles due to extremely high temperatures

Dead Simple Sites curates the most minimal sites on the web.

A lite demo server, inspired by Vite. Contribute to Jinjiang/vlite development by creating an account on GitHub.

Cliff Stoll (who is probably most famous for writing the wonderful Cuckoo's Egg about tracking a hacker when doing so was almost recreatio...

Next week, a fairly rare ceremony will take place in and around the Tower of London, and it's even more special than usual this time.

How can the world reach net zero if it keeps inventing new ways to consume energy?

Explore the ingenious method behind the One Billion Row Challenge's fastest temperature parsing technique, featuring a deep dive into Quân Anh Mai's (@merykitty) optimization code without loops or if statements, leveraging bitwise operations and ALU magic…

Data and protocol interoperability standards are needed for EDA tools, and there are more hurdles ahead. Customized chiplets will be required for AI applications.

Toyota, the world’s largest automaker, has been criticized for selling few electric vehicles, but its decision to focus on hybrids is paying off financially.

As AI-generated content fills the Internet, it’s corrupting the training data for models to come. What happens when AI eats itself?

Retaining the STM32 name despite a shift to the 64-bit Arm Cortex-A35 core, STMicro's latest STM32 parts pack in the power.

The disease once guaranteed an early death—but a new treatment has given many patients a chance to live decades longer than expected. What do they do now?

Energy efficiency of electronic digital processors is primarily limited by the energy consumption of electronic communication and interconnects. The industry is almost unanimously pushing towards...

Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (Cboe Canada MMED), (the “Company” or “MindMed”), a clinical stage biopharmaceutical company developing n

Two years ago, I wrote here about a new drug that was up for approval for ALS patients (who sadly have very few therapeutic options at all). The drug (Relyvrio, a mixture of sodium phenylbutyrate and taurursodiol) had been put through a Phase II trial by…